Lazarevic V

The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.

von Palffy S, Thorsson H, Peña-Martínez P, ..., Lilljebjörn H, Fioretos T

Blood Adv - (-) - [2022-11-16; online 2022-11-16]

Clinical Genomics Lund [Service]

Single base substitution and insertion/deletion mutational signatures in adult core binding factor acute myeloid leukemia.

Gunnarsson R, Yang M, Biloglav A, ..., Paulsson K, Johansson B

Leukemia 36 (6) 1681-1684 [2022-06-00; online 2022-04-01]

NGI Short read [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia.

Pettersson L, Johansson Alm S, Almstedt A, ..., Fogelstrand L, Ehinger M

Int J Lab Hematol 43 (4) 664-674 [2021-08-00; online 2021-05-30]

Clinical Genomics Gothenburg [Collaborative]

Clonal competition within complex evolutionary hierarchies shapes AML over time.

Sandén C, Lilljebjörn H, Orsmark Pietras C, ..., Ågerstam H, Fioretos T

Nat Commun 11 (1) 579 [2020-02-05; online 2020-02-05]

Clinical Genomics Lund